At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
Nicotine +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids[SALTVAPE Study]
In Brief
A clinical study evaluating Nicotine, Vaporizer Device, and 3 other interventions for Nicotine Dependence. Completed, enrolled 15 participants across 1 site.
Detailed Summary
This trial studies activity of time (pharmacokinetics), subjective effects, and abuse liability of nicotine salt-based vaping products with tobacco or e-liquids. This study aims to determine and compare the levels of nicotine delivered to the bloodstream from nicotine salt and free-base nicotine e-liquid solutions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNicotine Dependence
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJan 2020
Enrollment StartFeb 2020
Primary CompletionJul 2024
TodayJul 2026
First PostedJan 18, 2020
Enrollment StartFeb 18, 2020
Primary CompletionJul 10, 2024
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 6.5 years ago
Interventions
Nicotinedrug
Vape Free-Low nicotine unflavored
Vaporizer Devicedevice
Take puffs from vaporizer filled with different flavors
Salt-HIgh Nicotine Unflavored (Product B)drug
Vape Salt-High nicotine unflavored
Free-Low Nicotine Tobacco Flavored (Product C)drug
Vape Free-Low Nicotine Tobacco
Salt-High Nicotine Tobacco Flavored (Product D)drug
Vape Salt-High Tobacco